Neurocrine Biosciences Inc (NASDAQ:NBIX) - Share price - Overview

Stock Report

Neurocrine Biosciences Inc NBIX

Last Price
$41.64

Day Change
-0.71|-1.68%

As of 28/03/2017
16:00:00 EDT | USD
Minimum 15 Minutes Delay.

Last Close42.35
Day Range41.46 - 42.55
Mkt Cap-
52-Wk Range33.56 - 55.15
Yield %-
ISINUS64125C1099
Volume470,443
P/E-25.55
P/S243.90
P/CF-34.01

Share Price

Financials
201420152016
More ...
Income Statement
Revenue0.0019.7715.00
Operating Income-64.41-94.20-147.37
Net Income-60.54-88.93-141.09
Basic EPS-0.81-1.05-1.63
Avg. Diluted Shares Outstanding758487
Balance Sheet
Current Assets198.20384.07310.44
Non Current Assets44.8390.7154.64
Total Assets243.03474.79365.09
Current Liabilities15.6625.7230.41
Total Liabilities34.3350.3350.21
Total Equity208.70424.45314.88
Cash Flow
Operating Cash Flow-47.14-38.00-106.18
Capital Expenditure-1.61-1.93-4.11
Free Cash Flow-48.75-39.93-110.29

In millions, except "Basic EPS". Currency is USD.

Company Profile

Neurocrine Biosciences Inc discovers, develops and commercializes drugs for the treatment of neurological and endocrine-related diseases and disorders.

Sector

Healthcare

Industry

Biotechnology

Stock Style

Small-Growth

Fiscal Year Ends

December

Employees

196
Key Stats
More ...
Price/Earning TTM-25.98
Price/Book11.72
Price/Sales TTM244.37
Rev Growth (3 year avg)72.56
EPS Growth (3 year avg)-
Operating Margin % TTM-982.48
Net Margin % TTM-940.60
ROE TTM-38.17
Debt/Equity-
Dividends
PreviousLatest
More ...
Declared Datet.b.c.t.b.c.
Ex-Divt.b.c.29/12/95
Paidt.b.c.t.b.c.
Amnt0.000.04
AJ Bell includes AJ Bell Holdings Limited and its wholly owned subsidiaries. AJ Bell Management Limited and AJ Bell Securities Limited are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at Trafford House, Chester Road, Manchester M32 0RS. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2017 Morningstar. All rights reserved.